XML 72 R55.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Taxes
The U.S. and foreign components of income before income taxes were as follows:
Years Ended December 31,
(in millions)202420232022
U.S.$253.9 $199.5 $11.8 
Foreign
46.3 15.1 (2.0)
Income before income taxes$300.2 $214.6 $9.8 
Schedule of Income Tax (Benefit) Provision
The provision for income taxes consists of the following: 
Years Ended December 31,
(in millions)202420232022
Current:
Federal
$5.8 $— $— 
State
6.4 3.7 1.3 
Foreign
6.6 4.1 4.8 
Total current tax expense
18.8 7.8 6.1 
Deferred:
Federal
(111.1)0.1 — 
State(18.6)— — 
Foreign
(7.2)0.4 (0.9)
Total deferred tax (benefit) expense
(136.9)0.5 (0.9)
Income tax (benefit) expense
$(118.1)$8.3 $5.2 
Schedule of Reconciliations of the Federal Statutory Rate
Reconciliations of the U.S. federal statutory rate to the Company’s effective tax rate are as follows:
 Years Ended December 31,
 202420232022
U.S. federal statutory rate
21.0 %21.0 %21.0 %
Foreign tax rate differential
1.1 0.6 13.2 
State taxes, net of federal benefit2.3 2.4 (5.0)
Federal and state R&D credits
(4.4)(5.9)(49.4)
Stock-based compensation0.5 (3.2)(94.8)
Non-deductible officers’ compensation0.6 1.3 52.4 
Permanent items
1.1 0.7 6.3 
Foreign income taxed in the U.S.0.9 0.7 14.5 
Change in valuation allowance(59.8)(10.8)124.4 
Tax rate changes— 0.5 (30.9)
Change to prior year R&D credit
(2.8)(2.8)— 
Other0.2 (0.6)1.7 
Effective tax rate(39.3)%3.9 %53.4 %
Schedule of Unrecognized Tax Benefits
The following table summarizes the activity related to the Company’s unrecognized tax benefits:
Years Ended December 31,
(in millions)20242023
Unrecognized tax benefits at beginning of year
$5.0 $— 
Additions related to current period tax positions
2.7 2.6 
Additions related to prior period tax positions
5.1 2.4 
Unrecognized tax benefits at end of year
$12.8 $5.0 
Schedule of Company's Deferred Tax Assets (Liabilities)
The components of the net deferred tax asset were as follows:
 As of December 31,
(in millions)20242023
Deferred tax assets:
Net operating loss carryforwards$23.4 $91.4 
Tax credits56.6 54.1 
Capitalized research and development expenditures78.8 53.3 
Accrued expenses34.4 25.1 
Amortization of debt discount4.2 7.8 
Inventory capitalization8.2 6.5 
Intangible assets6.4 8.0 
Incentive compensation14.7 13.5 
Stock-based compensation10.2 8.0 
Other7.1 5.4 
Total deferred tax assets244.0 273.1 
Deferred tax liabilities:
Prepaid assets(9.3)(7.7)
Property, plant and equipment(47.4)(38.1)
Capitalized contract acquisition costs(13.1)(10.4)
Unrealized gains on cash flow hedges(1.2)(5.1)
Other(7.4)(7.7)
Total deferred tax liabilities(78.4)(69.0)
Net deferred tax asset before valuation allowance165.6 204.1 
Valuation allowance(23.9)(202.9)
Net deferred tax asset$141.7 $1.2 
Schedule of Net Operating Loss and Tax Credit Carryforwards
As of December 31, 2024, the Company’s net operating loss carryforwards were as follows:
(in millions)
Expiration Period
Net Operating Loss Carryforwards
U.S. federal
2029
$54.9 
State
2025 - 2042
$203.1 
Foreign
Indefinite
$1.7 
As of December 31, 2024, the Company’s tax credit carryforwards were as follows:
(in millions)
Expiration Period
Tax Credit Carryforwards
U.S. federal
2025 - 2044$44.3 
State2025 - 2044$30.7